No. of Recommendations: 3
https://finance.yahoo.com/quote/MEI don't think I need to post a summary, they are I purchased a very small amount of this (think dinner with desserts and wine for four at a nice restaurant), without much though. At $170M it is soundly a microcap, and it has gotten to that status the hard way. It is down 80% YoY, and down 97% from their peak. They are circling the drain, by appearances.
My thesis is pretty simple, their genomics data alone is worth more than their current valuation. And their drug discovery pharmogenetics is interesting, but probably nothing. I'm digging into the finances, but at first glance, their finance are awful. I will probably post and update that I've sold or bought more.